MENSCHLICHE ANTIKÖRPER GEGEN PD-L1

European patent · EP3473648 · In force

Register entry

Publication number
EP3473648
Application number
EP18206830
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 23, 2015
Published
Apr 24, 2019
Granted
Jun 2, 2021
Protection ends at the latest
Jan 22, 2035
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/28 (2006.01)
C07K 16/30 (2006.01)
A61K 39/395 (2006.01)
C07K 16/22 (2006.01)
A61P 35/00 (2006.01)
A61P 31/14 (2006.01)
A61P 31/18 (2006.01)
A61P 31/20 (2006.01)
A61P 37/02 (2006.01)
A61K 39/00 (2006.01)
Priority
US 201461930582 P 23.01.2014
US 201462089549 P 09.12.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Apr 13, 2022

    Change

    Published in Swissreg on 13.04.2022

  6. Jun 3, 2021

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 03.06.2021

  7. Jun 2, 2021

    Granted

    Published in Swissreg on 02.06.2021

Parties

Holder

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

THURSTON, Gavin

Tarrytown, NY 10591, US

MURPHY, Andrew, J.

Tarrytown, NY 10591, US

PAPADOPOULOS, Nicholas, J.

Tarrytown, NY 10591, US

IOFFE, Ella

Tarrytown, NY 10591, US

BUROVA, Elena

Tarrytown, NY 10591, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.